期刊文献+

分泌肿瘤坏死因子的基因工程细胞对HepG2细胞的抑制作用

Inhibitory Effects on HepG2 Cells from Genetic Engineering Cells Secreted Tumor Necrosis Factor
暂未订购
导出
摘要 目的自行建立分泌人肿瘤坏死因子α的基因工程细胞,将其与肝癌细胞共培养,观察体外培养中分泌肿瘤坏死因子hTNF/293基因细胞表达的情况及对人肝癌细胞的抑制作用。方法 (1)建立可稳定分泌人肿瘤坏死因子α/293细胞;采用RT-PCR、Western blot、ELISA和流式细胞仪等技术检测人肿瘤坏死因子表达和分泌;(2)观察体外培养中分泌肿瘤坏死因子hTNF/293基因细胞对人肝癌细胞的抑制作用,于不同的时间点,用MTT法检测490 nm下的吸光度值。结果 RT-PCR、Western blot和ELISA等技术检测表明hTNFα/293细胞组和TNFα阳性组对共培养的HepG2细胞的增殖具有明显的抑制作用,且具有良好的量效关系。结论提示TNF-α/293基因细胞可有效分泌hTNFα蛋白,并能分泌到细胞外;体外培养的人肿瘤坏死因子基因的工程细胞,所分泌肿瘤坏死因子α对人肝癌细胞增殖有明显抑制效应,且呈现出良好的数量依赖关系。 Objective To explore the effects of genetic engineering cells which secreted tumor necrosis factor(TNFα) co-cultured with human hepatic cancer cells HepG2 on the proliferation of cancer cells.Methods The expression and secreting of tumor necrosis factor was detected by RT-PCR,Western blot,ELISA and flow cytometry from the 293 cells which could stably secrete TNF-α.The inhibitory effects on the hepatic cancer cells HepG2 from the 293 cells(hTNFα/293) were detected by MTT assay under the wavenumber of 490 nm at different time.Results The results from RT-PCR,Western blot and ELISA indicated that hTNF-α/293 cells and TNF-α-positive group had significant inhibition on the proliferation of hepatic cancer cells in a dose-dependent manner.Conclusion The TNF-α/293 cells can effectively secrete TNF-α.And the TNF-α secreted from the genetic engineering cells has an inhibition on hepatic cancer cell proliferation in a dose-dependent manner.
出处 《肿瘤防治研究》 CAS CSCD 北大核心 2012年第8期944-946,共3页 Cancer Research on Prevention and Treatment
关键词 人肝癌细胞HEPG2 人肿瘤坏死因子Α 人胚胎肾细胞-293 HepG2 cells Human tumor necrosis factor-α Human embryonic kidney cell-293
  • 相关文献

参考文献12

  • 1Balaro A, Lembo S, Cirillo T, et al. Anti-Tumor Necrosis Factor-a Therapy in the Management of Psoriasis and B-Chronic Lympho?cytic Leukemia[J]. Case Rep Dermaiol ,2011 ,3(1) :60-3.
  • 2Shaw J, Chen 13, Huang WH, et al. The small-molecule TNF-alpha modulator, UTL-5g, reduces side effects induced by cispl?atin and enhances the therapeutic effect of cisplatin in vivo[J]. J Exp Ther Oncol,2011 ,9(2) :129-37.
  • 3Zhao X,Sun X,Gao F,et al. Effects of ulinastatin and docaiaxel on breast tumor growth and expression of IL-6, IL-8, and TNF-a[J]. J Exp Clin Cancer Res,2011 ,30(1) :22.
  • 4Xie Yv Bai O,Zhang H,et al. Tumor necrosis factor gene-engi?neered J558 tumor cell-released exosornes stimulate tumor an?tigen PI A-specific CD8( + ) CTL responses and antitumor im?munity[J]. Cancer Biorher Radiopharm,2010,25(l) :21-8.
  • 5Hamaguchi T, Wakabayashi H, Matsumine A, et al. TNF in?hibitor suppresses bone metastasis in a breast cancer cell line [J]. Biochem Biophys Res Commun,2011 ,407(3) :525-30.
  • 6Murugesan SR, King CR, Osborn R, et al, Combination of hu?man tumor necrosis factor-alpha (hTNF-alpha) gene delivery with gemcitabine is effective in models of pancreatic cancer[J]. Cancer Gene Ther, 2009, 16(11) : 841-7.
  • 7Xu Z, Vu T, Lee H, et al. Population pharmacokinetics of goli?mumab,an anti-tumor necrosis lacror-alpha human monoclonal antibody,in patients with psoriatic arthritis[J]. J Clin Pharma?col,2009,49 (9) :1056-70.
  • 8Keystone EC,Genovese MC, Klareskog L, et al. Golimumab, a human antibody to tumour necrosis factor α given by monthly subcutaneous injections, in active rheumatoid arthritis despite methotrexate therapy: the GO-FORWARD Study [J]. Ann Rheum Dis, 2009,68 (6) : 789-96.
  • 9Zhang J H, Wan MX, Pan BR, et al. Cytotoxicity of I-lSVtk and hrTNF-alpha fusion genes with IRES in treatment of gastric canccr[J]. Cancer Lett,2006,235(2): 191-201.
  • 10Sanlioglu AD, Aydin C, Bozcuk H, et al. Fundamental princi?pals of tumor necrosis factor-alpha gene therapy approach and implications for patients with lung carcinoma[J]. Lung Cancer, 2004,44(2): 199-211.

二级参考文献9

  • 1刘海峰,袁爱力,刘思德,周殿元.肿瘤坏死因子联合环磷酰胺对H_(22)肝癌小鼠的抗肿瘤作用[J].癌症,1994,13(6):509-513. 被引量:6
  • 2Ramesh G,Reeves WB. TNF-alpha mediates chemokine and cytokine expression and renal injury in cisplatin nephrotoxicity[J]. J Clin Invest,2002,110(6):835-842.
  • 3Wen JM,Huang JF,Hu L,et al. Establishment and characterization of human metastatic hepatocellular carcinoma cell line[J]. Cancer Genet Cytogenet,2002,135(1):91-95.
  • 4Liu SQ,Saijo K,Todoroki T,et al. Induction of human autologous cytotoxic T lymphocytes on formalin-fixed and paraffin-embedded tumour sections[J]. Nat Med,1995,1(3):267-271.
  • 5Kawakami K,Kawakami M,Puri RK. Cytokine receptor as a sensitizer for targeted cancer therapy[J]. Anticancer Drugs,2002,13(7):693-699.
  • 6Baxevanis CN,Voutsas IF,Tsitsilonis OE,et al. Compromised antitumor responses in tumor necrosis factor-alpha knockout mice[J]. Eur J Immunol,2000,30(7):1957-1966.
  • 7Szlosarek PW,Balkwill FR. Tumour necrosis factor alpha:a potential target for the therapy of solid tumours[J]. Lancet Oncol,2003,4(9):565-573.
  • 8Sacchi A,Gasparri A,Curnis F,et al. Crucial role for interferon gamma in the synergism between tumor vasculature-targeted tumor necrosis factor alpha (NGR-TNF) and doxorubicin[J]. Cancer Res,2004,64(19):7150-7155.
  • 9彭宝岗,丁健,吕明德,陈陵际,黄洁夫,陆丽娟.人肝癌裸小鼠原位移植模型的建立与鉴定[J].中山大学学报(医学科学版),1996,16(S1):7-10. 被引量:6

共引文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部